ENERZAIR BREEZHALER inha+capt 150/50/160mcg 30 pce
7680675960064
CH-67596
R03AL12
Reimbursement limitations:
ENERZAIR
Pour le traitement d'entretien des patients souffrant d'asthme sévère qui ne sont pas suffisamment contrôlés …
1 / 2
bing
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
160.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67596
- Drug name
- Enerzair Breezhaler, Hartkapsel mit Pulver zur Inhalation
- Galenic form
- KAHI
- ATC Code
- R03AL12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/09/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENERZAIR BREEZHALER inha+capt 150/50/160mcg 30 pce
- Description (DE)
- ENERZAIR BREEZHALER Inha+Sens 150/50/160mcg 30 Stk
- Market launch
- 24/09/2020
- Narcotic (BTM)
- No